Germany's Merck KGaA Agrees to Buy Sigma-Aldrich for $17 Billion

Germany

SUGAR LAND--September 25, 2014--Researched by Industrial Info Resources (Sugar Land, Texas)--Pharmaceuticals titan Merck KGaA (NYSE:MRK) (Darmstadt, Germany) announced an agreement to buy the chemical company Sigma-Aldrich Corporation (NASDAQ:SIAL) for $17 billion. According to the agreement, Merck offered $140 per share, or a 37% premium over September 19 closing price. The company says it expects the deal with close in the middle of next year.

Within this article: Information on the potential acquisition.

Subscribe Now!(All Fields Required)

Articles related to this company

Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
Turner Construction Involved in More than $24 Billion Worth of U.S. Project...
Medical Devices & Equipment Sector Brings Billions in Spending to the U.S.

All Members Receive the Following Resources:

Industry News Digest
Upcoming Webinars
On-Demand Webinars
The NavigatIIR Newsletter
Economic Indicators

Germany's Merck KGaA Agrees to Buy Sigma-Aldrich for $17 Billion